Replies to post #115875 on Biotech Values

[genisi]

GILD has only few years left before Letairis goes off patent*, to try and take more market share from Tracleer that still has that warning in its label.

* http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=022081&Product_No=002&table1=OB_Rx